Last update 23 Jan 2025
Shenzhen Fifth People's Hospital

Shenzhen Fifth People's Hospital

Hospital|
2003|
Guangdong Sheng, China

Overview

Tags

Congenital Disorders
Endocrinology and Metabolic Disease
Digestive System Disorders
CAR-T

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Neoplasms1
Top 5 Drug TypeCount
CAR-T1
Top 5 TargetCount
CLDN18.2(Claudin 18.2)1

Related

1
Drugs associated with Shenzhen Fifth People's Hospital
HEC-016
Target
CLDN18.2
Mechanism
CLDN18.2 inhibitors
Active Org.
Shenzhen Fifth People's HospitalShenzhen Fifth People's Hospital
Originator Org.
Sunshine Lake Pharma Co., Ltd.Sunshine Lake Pharma Co., Ltd.
Active Indication
Advanced Gastroesophageal Junction Adenocarcinoma [+2]
Inactive Indication-
Drug Highest PhaseEarly Phase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Shenzhen Fifth People's Hospital
NCT05277987
/ RecruitingEarly Phase 1IIT
A Single Arm, Open Lable and Single Site Early Phase I Clinical Trial to Evaluate the Safety, Cell Kinetics and Initial Efficacy About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects
100 Clinical Results associated with Shenzhen Fifth People's Hospital
Login to view more data
0 Patents (Medical) associated with Shenzhen Fifth People's Hospital
Login to view more data
100 Deals associated with Shenzhen Fifth People's Hospital
Login to view more data
100 Translational Medicine associated with Shenzhen Fifth People's Hospital
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
HEC-016
 ( CLDN18.2 )		Advanced Gastroesophageal Junction Adenocarcinoma
More
Phase 1 Clinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free